Which of the following transdermal products is used once weekly?

Szasz and Hollender developed a framework to describe the dynamics of the patient-provider relationship based on the patient's level of function. These models describe how clinical authority is distributed during the therapeutic encounter. The choice of model often depends on the severity of the medical condition and the patient's ability to contribute to their own care. Understanding these models helps practitioners adapt their communication style to improve outcomes.

Rationale:

A. Activity-passivity is a model where the practitioner is entirely in control and the patient is a passive recipient of care. This occurs in emergency situations, such as when a patient is unconscious or in a coma. There is no opportunity for partnership because the patient cannot communicate. It represents the most paternalistic end of the care spectrum.

B. Guidance-cooperation occurs when the practitioner tells the patient what to do, and the patient complies with the instructions. This is common in acute infections where the doctor prescribes an antibiotic and the patient follows the regimen. While there is cooperation, it is not a true partnership, as the provider retains the majority of the decision-making power.

C. Mutual participation is the correct term for a partnership where the patient and practitioner work together as equals. This model is most effective for chronic disease management, such as diabetes, where the patient's daily choices are vital. It involves shared decision-making and recognizes the patient as an expert in their own life experience and health goals.

Debrox is an otic solution containing carbamide peroxide 6.5%, used primarily as an earwax (cerumen) removal aid. When applied to the ear canal, it releases oxygen, causing a foaming action that softens and loosens impacted wax. Proper administration is critical to avoid otic irritation or damage to the tympanic membrane. Treatment is generally limited to a specific duration before medical consultation is required.

Rationale:

A. True is incorrect because the specific dosage range and frequency provided do not match the standard FDA-approved labeling for this otic medication. While the medication is used for cerumen removal, the clinical guidelines dictate a higher drop count to ensure adequate saturation of the wax within the external auditory canal.

B. False is the correct answer because the standard adult dose for Debrox is 5 to 10 drops, not 1 to 5. The frequency is twice daily for up to 4 days. Providing only 1 to 5 drops may result in sub-therapeutic coverage, failing to effectively emulsify the impacted cerumen for subsequent irrigation.